GSE210693
Effect of PPARG modulators on gene expression in HT-1197 cells.
To investigate gene expression changes in a bladder cancer cell line with RXRA p.S427F hotspot mutation after 24 hour treatment with PPARG agonist, rosiglitzone, and PPARG inverse-agonists; T0070907, SR10221, and BAY-4931 Overall design: Comparative gene expression profiling analysis of RNA-seq data for HT-1197 cells after 24 hour treatment with PPARG modulators. Samples in biological triplicates.